| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.0033 | 1 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.011 | 1 |